SS Innovations develops surgical robotics, led by its SSi Mantra system designed as a more cost-accessible alternative for multi-specialty procedures, including cardiac surgery. The platform is complemented by instruments, training tools and related robotic technologies aimed at hospitals seeking robotic capability without the highest-end price tiers. Founded by a robotic cardiac surgeon, the company positions itself around making advanced robotic surgery more widely available.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 10 | — | -0.3 | — |
| Q3 2025 | 12.8 | — | -3.7 | — |
| Q4 2025 | 14.5 | — | -2.5 | — |
| Q1 2026 | 11.1 | — | -3.6 | — |
| Q2 2026 | 13.9 | 39.4% | -2.7 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Bright Minds Biosciences Inc. (DRUG), Powerlaw Corp. (PWRL), Nexxen International Ltd. (NEXN), The York Water Company (YORW), REalloys Inc. (ALOY), Orange County Bancorp, Inc. (OBT)